We are live on ! Find out more
ANEB

Anebulo Pharmaceuticals
ANEB

Delisted

ANEB was delisted on the 27th of February, 2026.

Back to rankings

Fund managers haven’t disclosed any holdings of ANEB yet.

ANEB Hedge Fund Activity: Q1 2026 in Review

0 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Anebulo Pharmaceuticals (ANEB) for Q1 2026, worth a combined $0 — down 100% from $91.6M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of ANEB and 0 opened new positions — a net loss of 18 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was 22NW LP, exiting entirely with an estimated $84.8M sold.

  • 0 institutional investors held Anebulo Pharmaceuticals (ANEB) as of Q1 2026, down from 19 in Q4 2025.
  • Funds reported $0 of Anebulo Pharmaceuticals stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Anebulo Pharmaceuticals positions in Q1 2026 and 18 closed out, a net change of -18 holders.
  • The largest Anebulo Pharmaceuticals seller in Q1 2026 was 22NW LP, an estimated $84.8M sold.

Based on aggregated 13F filings for Q1 2026.